Terms: = Ovarian cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Treatment
75 results:
1. Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous ovarian Carcinoma.
Wenk D; Khan S; Ignatchenko V; May T; Bernardini MQ; Kislinger T
J Proteome Res; 2024 Feb; 23(2):749-759. PubMed ID: 38266179
[TBL] [Abstract] [Full Text] [Related]
2. Akt-Activated Endothelium Increases cancer Cell Proliferation and Resistance to treatment in ovarian cancer Cell Organoids.
Hoarau-Véchot J; Blot-Dupin M; Pauly L; Touboul C; Rafii S; Rafii A; Pasquier J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430649
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of hci-EC-23 a novel estrogen- and progesterone-responsive endometrial cancer cell line.
Rush CM; Blanchard Z; Polaski JT; Osborne KS; Osby K; Vahrenkamp JM; Yang CH; Lum DH; Hagan CR; Leslie KK; Pufall MA; Thiel KW; Gertz J
Sci Rep; 2022 Nov; 12(1):19731. PubMed ID: 36396974
[TBL] [Abstract] [Full Text] [Related]
4. The protective effect of erythropoietin on ischemia- reperfusion injury caused by ovarian torsion-detorsion in the experimental rat model.
Kartal B; Bozkurt MF; Alimoğullari E; Saçık U
J Histotechnol; 2023 Jun; 46(2):57-64. PubMed ID: 36164847
[TBL] [Abstract] [Full Text] [Related]
5. Sitagliptin Modulates the Response of ovarian cancer Cells to Chemotherapeutic Agents.
Kosowska A; Garczorz W; Kłych-Ratuszny A; Aghdam MRF; Kimsa-Furdzik M; Simka-Lampa K; Francuz T
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33256016
[TBL] [Abstract] [Full Text] [Related]
6. timp-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells.
Escalona RM; Bilandzic M; Western P; Kadife E; Kannourakis G; Findlay JK; Ahmed N
BMC Cancer; 2020 Oct; 20(1):960. PubMed ID: 33023532
[TBL] [Abstract] [Full Text] [Related]
7. Expression of Matrix Metalloproteinases and Their Inhibitors in Endometrium: High Levels in Endometriotic Lesions.
Luddi A; Marrocco C; Governini L; Semplici B; Pavone V; Luisi S; Petraglia F; Piomboni P
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325785
[TBL] [Abstract] [Full Text] [Related]
8. timp-1 is Overexpressed and Secreted by Platinum Resistant Epithelial ovarian cancer Cells.
Sonego M; Poletto E; Pivetta E; Nicoloso MS; Pellicani R; Vinciguerra GLR; Citron F; Sorio R; Mongiat M; Baldassarre G
Cells; 2019 Dec; 9(1):. PubMed ID: 31861382
[TBL] [Abstract] [Full Text] [Related]
9. Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study.
Khalil C; Moussa M; Azar A; Tawk J; Habbouche J; Salameh R; Ibrahim A; Alaaeddine N
J Ovarian Res; 2019 Jul; 12(1):70. PubMed ID: 31351482
[TBL] [Abstract] [Full Text] [Related]
10. Physcion 8-O-β-glucopyranoside exhibits anti-growth and anti-metastatic activities in ovarian cancer by downregulating miR-25.
Xue CL; Liu HG; Li BY; He SH; Yue QF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5101-5112. PubMed ID: 31298363
[TBL] [Abstract] [Full Text] [Related]
11. Suppression of autophagy enhances preferential toxicity of epothilone A and epothilone B in ovarian cancer cells.
Rogalska A; Gajek A; Marczak A
Phytomedicine; 2019 Aug; 61():152847. PubMed ID: 31029905
[TBL] [Abstract] [Full Text] [Related]
12. Alpinetin inhibits proliferation and migration of ovarian cancer cells via suppression of STAT3 signaling.
Zhao X; Guo X; Shen J; Hua D
Mol Med Rep; 2018 Oct; 18(4):4030-4036. PubMed ID: 30132572
[TBL] [Abstract] [Full Text] [Related]
13. Expression of the Major Vault Protein (MVP) and Cellular Vault Particles in Fish.
Margiotta AL; Bain LJ; Rice CD
Anat Rec (Hoboken); 2017 Nov; 300(11):1981-1992. PubMed ID: 28710803
[TBL] [Abstract] [Full Text] [Related]
14. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells.
Zhou G; Peng F; Zhong Y; Chen Y; Tang M; Li D
Int J Oncol; 2017 Mar; 50(3):933-941. PubMed ID: 28098862
[TBL] [Abstract] [Full Text] [Related]
15. Therapeutic Effects of Punicalagin Against ovarian Carcinoma Cells in Association With β-Catenin Signaling Inhibition.
Tang JM; Min J; Li BS; Hong SS; Liu C; Hu M; Li Y; Yang J; Hong L
Int J Gynecol Cancer; 2016 Nov; 26(9):1557-1563. PubMed ID: 27540692
[TBL] [Abstract] [Full Text] [Related]
16. [Erythropoietin and drug resistance in breast and ovarian cancers].
Szenajch JM; Synowiec AE
Ginekol Pol; 2016; 87(4):300-4. PubMed ID: 27321103
[TBL] [Abstract] [Full Text] [Related]
17. Hematological toxicity of carboplatin for gynecological cancer according to body mass index.
Gutierrez F; Gonzalez-de-la-Fuente GA; Nazco GJ; Oramas J; Batista N
Eur J Clin Pharmacol; 2016 Sep; 72(9):1083-9. PubMed ID: 27287195
[TBL] [Abstract] [Full Text] [Related]
18. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract] [Full Text] [Related]
19. Why a Combination of WP 631 and epo B is an Improvement on the Drugs Singly - Involvement in the Cell Cycle and Mitotic Slippage.
Bukowska B; Rogalska A; Forma E; Brys M; Marczak A
Asian Pac J Cancer Prev; 2016; 17(3):1299-308. PubMed ID: 27039763
[TBL] [Abstract] [Full Text] [Related]
20. New potential chemotherapy for ovarian cancer - Combined therapy with WP 631 and epothilone B.
Bukowska B; Rogalska A; Marczak A
Life Sci; 2016 Apr; 151():86-92. PubMed ID: 26944437
[TBL] [Abstract] [Full Text] [Related]
[Next]
